Published in Eur Spine J on June 16, 2009
Pedicle screw loosening: a clinically relevant complication? Eur Spine J (2015) 0.98
Late infections after dynamic stabilization of the lumbar spine with Dynesys. Eur Spine J (2012) 0.84
The Effects of Spinopelvic Parameters and Paraspinal Muscle Degeneration on S1 Screw Loosening. J Korean Neurosurg Soc (2015) 0.75
Comparison of the Dynesys Dynamic Stabilization System and Posterior Lumbar Interbody Fusion for Lumbar Degenerative Disease. PLoS One (2016) 0.75
Non-fusion procedure using PEEK rod systems for lumbar degenerative diseases: clinical experience with a 2-year follow-up. BMC Musculoskelet Disord (2016) 0.75
The Change of Sagittal Alignment of the Lumbar Spine after Dynesys Stabilization and Proposal of a Refinement. J Korean Neurosurg Soc (2015) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Internal fixation of the lumbar spine with pedicle screw plating. Clin Orthop Relat Res (1986) 3.54
Complications associated with pedicle screws. J Bone Joint Surg Am (1999) 3.41
The dynamic neutralization system for the spine: a multi-center study of a novel non-fusion system. Eur Spine J (2002) 2.60
Analysis of the morphometric characteristics of the thoracic and lumbar pedicles. Spine (Phila Pa 1976) (1987) 2.49
Clinical experience with the Dynesys semirigid fixation system for the lumbar spine: surgical and patient-oriented outcome in 50 cases after an average of 2 years. Spine (Phila Pa 1976) (2005) 2.31
Complications of transpedicular lumbosacral fixation for non-traumatic disorders. J Bone Joint Surg Br (1997) 1.93
Anatomic and technical considerations of pedicle screw fixation. Clin Orthop Relat Res (1992) 1.91
Complications after transpedicular stabilization of the spine. A survivorship analysis of 163 cases. Spine (Phila Pa 1976) (1994) 1.81
Dynamic stabilization in addition to decompression for lumbar spinal stenosis with degenerative spondylolisthesis. Spine (Phila Pa 1976) (2006) 1.75
Biomechanical characterization of the three-dimensional kinematic behaviour of the Dynesys dynamic stabilization system: an in vitro study. Eur Spine J (2005) 1.66
Augmentation of pedicle screw fixation strength using an injectable calcium phosphate cement as a function of injection timing and method. Spine (Phila Pa 1976) (2004) 1.43
Segmental spine plates with pedicle screw fixation. A new internal fixation device for disorders of the lumbar and thoracolumbar spine. Clin Orthop Relat Res (1986) 1.41
Influence of a dynamic stabilisation system on load bearing of a bridged disc: an in vitro study of intradiscal pressure. Eur Spine J (2006) 1.34
Clinical outcomes of the Dynesys dynamic neutralization system: 1-year preliminary results. Neurosurg Focus (2007) 1.30
An internal fixator for posterior application to short segments of the thoracic, lumbar, or lumbosacral spine. Design and testing. Clin Orthop Relat Res (1986) 1.26
Fusion of the lumbar and sacral spine by internal fixation with screw plates. Clin Orthop Relat Res (1986) 1.20
Biomechanical evaluation and preliminary clinical experience with an expansive pedicle screw design. J Spinal Disord (2000) 1.12
The significance of radiolucent zones surrounding pedicle screws. Definition of screw loosening in spinal instrumentation. J Bone Joint Surg Br (2004) 1.10
The effect of surface macrotexture and hydroxylapatite coating on the mechanical strengths and histologic profiles of titanium implant materials. J Biomed Mater Res (1987) 1.09
The effect of movement on the holding power of screws in bone. Clin Orthop Relat Res (1975) 1.04
Insertional torque and pull-out strengths of conical and cylindrical pedicle screws in cadaveric bone. Spine (Phila Pa 1976) (1996) 1.04
Hydroxyapatite coating improves fixation of pedicle screws. A clinical study. J Bone Joint Surg Br (2002) 1.01
Optimizing bone screw pullout force. J Orthop Trauma (1990) 1.00
Histological and ultrastructural appearance of the hydroxyapatite-bone interface. J Biomed Mater Res (1990) 0.99
Clinical course and significance of the clear zone around the pedicle screws in the lumbar degenerative disease. Spine (Phila Pa 1976) (2008) 0.96
Hydroxyapatite-coating of pedicle screws improves resistance against pull-out force in the osteoporotic canine lumbar spine model: a pilot study. Spine J (2005) 0.95
Evaluation of hydroxylapatite-coated titanium dental implants in dogs. J Oral Maxillofac Surg (1987) 0.95
[System of dynamic neutralization in the lumbar spine: experience on 94 cases]. Neurocirugia (Astur) (2005) 0.94
Efficacy of novel-concept pedicle screw fixation augmented with calcium phosphate cement in the osteoporotic spine. J Orthop Sci (2005) 0.93
Hydroxyapatite dip coated and uncoated titanium poly-axial pedicle screws: an in vivo bovine model. Spine (Phila Pa 1976) (2006) 0.92
Hydroxyapatite composite resin cement augmentation of pedicle screw fixation. Clin Orthop Relat Res (2003) 0.89
Enhancement of pedicle screw stability using calcium phosphate cement in osteoporotic vertebrae: in vivo biomechanical study. J Orthop Sci (2003) 0.86
Spinal instrumentation in the management of degenerative disorders of the lumbar spine. Clin Orthop Relat Res (1997) 0.83
Hydroxyapatite coating enhances fixation of loaded pedicle screws: a mechanical in vivo study in sheep. Eur Spine J (2001) 0.83
Biological assessment of the bone-screw interface after insertion of uncoated and hydroxyapatite-coated pedicular screws in the osteopenic sheep. J Biomed Mater Res A (2003) 0.83
Microfracture and changes in energy absorption to fracture of young vertebral cancellous bone following physiological fatigue loading. Spine (Phila Pa 1976) (2004) 0.80
Morphologic and radioautographic studies of bone formation in relation to titanium implants using the rat tibia as a model. Int J Oral Maxillofac Implants (1995) 0.80
Hydroxylapatite-coated Diapason screws: first clinical report. J Spinal Disord (1995) 0.80
Pedicle screws: axial pull-out strength in the lumbar spine. Spine (Phila Pa 1976) (1988) 0.80
Structure of the bone interface to dental implants in vivo. J Oral Implantol (1993) 0.78
Enhancement of pedicle screw fixation through washers. Clin Orthop Relat Res (2002) 0.77
MINIATURE escherichia coli CELLS DEFICIENT IN DNA. Proc Natl Acad Sci U S A (1967) 19.02
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect (2000) 9.30
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature (1999) 7.47
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Effects of colchicine and related substances on cell division. Biochem J (1936) 5.80
Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res (2001) 5.78
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem (1981) 4.30
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04
Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: genetic organization and occurrence of conserved domains in isoenzymes. J Bacteriol (1998) 3.81
A clinical trial of active management of labor. N Engl J Med (1995) 3.34
The properties of DNA transferred to minicells during conjugation. Cold Spring Harb Symp Quant Biol (1968) 2.86
Primary cardiac valve tumors. Ann Thorac Surg (1991) 2.85
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell (1994) 2.69
Synthesis of linear plasmid multimers in Escherichia coli K-12. J Bacteriol (1986) 2.65
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
The relationship between gastroesophageal reflux and apnea in infants. J Pediatr (2000) 2.24
A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell (1984) 2.19
Postcholecystectomy biliary leaks in the laparoscopic era: risk factors, presentation, and management. McGill Gallstone Treatment Group. Gastrointest Endosc (1997) 2.15
Successful treatment of primary amebic meningoencephalitis. N Engl J Med (1982) 2.14
Percutaneous dilational tracheostomy. A bedside procedure on the intensive care unit. Anaesthesia (1991) 2.07
Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol (2009) 2.06
Predicting relapse in Crohn's disease: a biopsychosocial model. Gut (2008) 2.01
Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J (2003) 1.99
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med (1976) 1.91
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health (1989) 1.83
DNA isolated from Escherichia coli minicells mated with F+ cells. Proc Natl Acad Sci U S A (1968) 1.83
Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA (2001) 1.81
Regulation of muscle gene expression. The accumulation of messenger RNAs coding for muscle-specific proteins during myogenesis in a mouse cell line. J Mol Biol (1982) 1.79
Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell (1978) 1.78
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. Cancer (1984) 1.73
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet (1981) 1.69
Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta. Neurology (2004) 1.69
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J (1972) 1.68
Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A (1998) 1.68
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol (2001) 1.67
Intrapartum maternal fever and neonatal outcome. Pediatrics (2000) 1.65
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology (1996) 1.64
Nucleotide sequence and spatial expression pattern of a drought- and abscisic Acid-induced gene of tomato. Plant Physiol (1991) 1.62
The value of magnetic resonance imaging in our current management of ACL and meniscal injuries. Knee Surg Sports Traumatol Arthrosc (2007) 1.62
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Plasmidic recombination in Escherichia coli K-12: the role of recF gene function. Mol Gen Genet (1983) 1.61
Myotonic heart disease: a clinical follow-up. Neurology (1991) 1.60
Quality of community drinking water and the occurrence of late adverse pregnancy outcomes. Arch Environ Health (1993) 1.58
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
Three additional linkage groups that repress transcription and meiotic recombination in the mating-type region of Schizosaccharomyces pombe. Genetics (1994) 1.57
Nulliparas' preferences for epidural analgesia: their effects on actual use in labor. Birth (1999) 1.57
Outcomes of trial of labor following previous cesarean delivery among women with fetuses weighing >4000 g. Am J Obstet Gynecol (2001) 1.56
Decreased hospital utilization by older adults attributable to a home hospitalization program. J Am Geriatr Soc (1996) 1.53
Guidelines on the use and monitoring of heparin. Br J Haematol (2006) 1.51
Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry (2007) 1.51
Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematol (1997) 1.51
Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. Am J Cardiol (1966) 1.50
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr Biol (1998) 1.49
A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood (1995) 1.48
Excess female mortality in India: the case of Himachal Pradesh. Am J Public Health (2000) 1.48
Properties of a cell fraction that repairs damage to the cell division mechanism of Escherichia coli. J Bacteriol (1969) 1.45
Scurvy and altered iron stores in thalassemia major. N Engl J Med (1981) 1.45
Segmental tibial fractures: an assessment of procedures in 27 cases. Injury (2003) 1.44
The synthesis and stability of cytoplasmic messenger RNA during myoblast differentiation in culture. Proc Natl Acad Sci U S A (1974) 1.44
Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol (1991) 1.44
Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem (1998) 1.44
Patent foramen ovale: is stroke due to paradoxical embolism? Stroke (1993) 1.42
Genes for tryptophan biosynthesis in the archaebacterium Haloferax volcanii. Proc Natl Acad Sci U S A (1990) 1.42
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry. J Perinatol (2008) 1.41
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Epidurals and cesareans: the jury is still out. Birth (1999) 1.41
Insertional mutation of the mouse Msx1 homeobox gene by an nlacZ reporter gene. Mech Dev (1997) 1.40
Nutrition and quality of life in the aged: the Jerusalem 70-year olds longitudinal study. Aging (Milano) (2000) 1.40
A multiple-dose pharmacokinetic comparison of naproxen as a once-daily controlled-release tablet and a twice-daily conventional tablet. J Clin Pharmacol (1987) 1.40
Altered mRNA binding activity and decreased translational initiation in a nuclear mutant lacking translation of the chloroplast psbA mRNA. Mol Cell Biol (1996) 1.39
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplant (2005) 1.39
Late effects of transplantation. Gerard Socie, for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Lancet (1999) 1.39
Relative bioavailability of a new transdermal nitroglycerin delivery system. J Pharm Sci (1986) 1.39
The growth of ethics in medicine over the past 50 years. Med J Aust (2001) 1.39
Maternal epidural use and neonatal sepsis evaluation in afebrile mothers. Pediatrics (2001) 1.39
Contribution of hyperoxia to lipid peroxidation in coronary artery operations: should we keep a low oxygen tension? J Thorac Cardiovasc Surg (1997) 1.38
[A new cause of increased troponin levels: junctional tachycardia]. Arch Mal Coeur Vaiss (2003) 1.38
The weighted diagnostic distortion (WDD) measure for ECG signal compression. IEEE Trans Biomed Eng (2000) 1.37
Isolation, identification, and characterization in Israel of Brucella melitensis biovar 1 atypical strains susceptible to dyes and penicillin, indicating the evolution of a new variant. J Clin Microbiol (1990) 1.37
Paraprofessional delivery of a theory based HIV prevention counseling intervention for women. Public Health Rep (1996) 1.37
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood (1984) 1.36
Induction of SOS functions by alkaline intracellular pH in Escherichia coli. J Bacteriol (1986) 1.36
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol (1999) 1.35